HOMOLOGY MEDICINES, INC. (NASDAQ: FIXX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Homology Medicines, Inc. (NASDAQ: FIXX)
10 mai 2022 01h35 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Homology Medicines? If so, please visit Homology Medicines, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
HOMOLOGY MEDICINES, INC. (NASDAQ: FIXX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Homology Medicines, Inc. (NASDAQ: FIXX)
28 avr. 2022 00h30 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Homology Medicines? If so, please visit Homology Medicines, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
FIXX NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – FIXX
26 avr. 2022 11h24 HE
|
The Rosen Law Firm PA
NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. (NASDAQ: FIXX) between June...
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – FIXX
22 avr. 2022 15h10 HE
|
The Rosen Law Firm PA
NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. (NASDAQ: FIXX) between June 10,...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FIXX
16 avr. 2022 18h00 HE
|
The Rosen Law Firm PA
NEW YORK, April 16, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. (NASDAQ: FIXX) between June...
FIXX LOSS ALERT: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – FIXX
08 avr. 2022 18h15 HE
|
The Rosen Law Firm PA
NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. (NASDAQ: FIXX) between June...
HOMOLOGY MEDICINES, INC. (NASDAQ: FIXX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Homology Medicines, Inc. (NASDAQ: FIXX)
07 avr. 2022 06h15 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Homology Medicines? If so, please visit Homology Medicines, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
ROSEN, A LONGSTANDING LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – FIXX
31 mars 2022 17h15 HE
|
The Rosen Law Firm PA
NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
HOMOLOGY MEDICINES, INC. (NASDAQ: FIXX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Homology Medicines, Inc. (NASDAQ: FIXX)
31 mars 2022 07h05 HE
|
Bernstein Liebhard LLP
NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a...
Oxford Biomedica Appoints Dr. Sam Rasty as Non-Executive Director
23 nov. 2020 07h00 HE
|
Oxford BioMedica plc
Oxford Biomedica Appoints Dr. Sam Rasty as Non-Executive Director Oxford, UK – 23 November, 2020: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading gene and...